Form D · Biotechnology
Cour Pharmaceuticals Development Co Inc
Northbrook, IL · CIK 0001568153
Offering snapshot reported Jan 8, 2016 · SEC filing
- Reported sold
- $169K Offering amount: $169K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 31, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 8, 2016 | Initial | $169,251 | No comparison | 2 | SEC filing |
| Aug 28, 2014 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Apr 23, 2013 | Initial | $16,977 | No comparison | 1 | SEC filing |
| Feb 6, 2013 | Initial | $16,977 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-254774
Source: Form D, filed Jan 8, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daniel Getts | Director |
| James Herrmann | Director, Executive |
| Catherine Mackey | Director |
| John J. Puisis | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2215 Sanders Road, Suite 425
Northbrook, IL, 60062
Northbrook, IL, 60062